RNS Number : 8477N CRISM Therapeutics Corporation 27 July 2026
27 July 2026
CRISM Therapeutics Corporation
(“CRISM”, “CRISM Therapeutics” or the “Company”)
Results of Shareholder Analysis
CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, announces that following the completion of an independent third-party shareholder register analysis, that as at 30 June 2026, the Company is aware of the following significant shareholders, being those with an interest in 3% or more of the ordinary share capital of the Company (“Ordinary Shares”):
|
Shareholder |
No. of Ordinary Shares |
% interest in the ordinary share capital of the Company |
|
Miton UK… |
